These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23995112)

  • 1. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
    Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
    J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
    Dultz G; Kronenberger B; Azizi A; Mihm U; Vogl TJ; Sarrazin U; Sarrazin C; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Jul; 55(1):229-32. PubMed ID: 21310200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
    Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
    Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis.
    Olson MM; Ilada PB; Apelgren KN
    Surg Endosc; 2003 Aug; 17(8):1322. PubMed ID: 12799896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications.
    Kwon J; Koh Y; Yu SJ; Yoon JH
    Thromb Res; 2018 Mar; 163():71-76. PubMed ID: 29407630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Portal and superior mesenteric vein thrombosis after splenectomy for idiopathic thrombocytopenic purpura].
    Silberstein E; Smolikov A; Levi I
    Harefuah; 1999 Mar; 136(5):364-6, 418. PubMed ID: 10914240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombopoietin receptor agonists administration for acute exacerbation of chronic idiopathic thrombocytopenic purpura and subsequent anticoagulant therapy for accompanying deep venous thrombosis of the lower limbs].
    Kawano H; Suzuki T; Ishii S; Wakahashi K; Kawano Y; Sada A; Minagawa K; Takaya T; Yamashita T; Hirata K; Koriyama K; Nagamatsu Y; Matsui T; Katayama Y
    Rinsho Ketsueki; 2014 Jun; 55(6):697-702. PubMed ID: 24975340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia.
    Saito M; Morioka M; Izumiyama K; Mori A; Kondo T
    Cureus; 2021 Aug; 13(8):e17478. PubMed ID: 34589366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient].
    Nawata Y; Hamada K; Tajima H; Nishino N; Nakazawa T; Tobayashi K; Saitoh S
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1394-400. PubMed ID: 22863964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis.
    Matsui T; Usui M; Wada H; Iizawa Y; Kato H; Tanemura A; Murata Y; Kuriyama N; Kishiwada M; Mizuno S; Sakurai H; Isaji S
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):254-262. PubMed ID: 29050501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
    Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
    J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal vein thrombosis in hepatitis C virus-related cirrhotic patients: Prevalence and clinical characteristics in an Egyptian cohort.
    Alhaddad O; Elsabaawy M; Elshaaraawy O; Elhalawany M; Houseni MM; Abdelsameea E
    Trop Doct; 2021 Jul; 51(3):314-318. PubMed ID: 33663297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis.
    Senzolo M; Piano S; Shalaby S; Tonon M; Tonello S; Zanetto A; Sacerdoti D; Simioni P; Bombonato G; Burra P; Angeli P
    Am J Med; 2021 Oct; 134(10):1278-1285.e2. PubMed ID: 34197784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.
    Tanaka H; Horie Y; Idobe Y; Murawaki Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1998; 45(23):1777-80. PubMed ID: 9840147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dural Venous Sinus Thrombosis and Pulmonary Embolism Following Immunoglobulin Treatment in Pediatric Patient With Immune Thrombocytopenic Purpura.
    Park KM; Yang EJ; Lim YT
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e508-e511. PubMed ID: 29068869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.